secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2023-05-12T23:59:59+00:00
Accession:  0001683168-23-003243
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic Biosciences announces 1-for-10 reverse stock split effective May 15, 2023
--------------------------------------------------------------------------------

- Reverse split reduces outstanding shares from 15,166,596 to ~1,516,660; authorized shares from 100M to 10M.
- Effective 12:01 a.m. ET on May 15, 2023; no fractional shares – any fraction rounded up.
- Common stock continues trading on Nasdaq under symbol XBIO with new CUSIP 984015602.
- Warrants (XBIOW) and equity awards proportionately adjusted; no action required by holders.
- Press release issued May 12, 2023; Certificate of Change filed with Nevada Secretary of State.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316823003243/0001683168-23-003243-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316823003243/xenetic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-003243

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer